Handok Inc
KRX:002390

Watchlist Manager
Handok Inc Logo
Handok Inc
KRX:002390
Watchlist
Price: 11 250 KRW 0.45% Market Closed
Market Cap: 154.8B KRW

Relative Value

The Relative Value of one Handok Inc stock under the Base Case scenario is 29 173.55 KRW. Compared to the current market price of 11 250 KRW, Handok Inc is Undervalued by 61%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
29 173.55 KRW
Undervaluation 61%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
96
vs Industry
87
Median 3Y
0.3
Median 5Y
0.4
Industry
2.7
vs History
vs Industry
31
Median 3Y
-3
Median 5Y
-2.7
Industry
21.5
vs History
38
vs Industry
44
Median 3Y
3.9
Median 5Y
7.4
Industry
16.7
vs History
63
vs Industry
34
Median 3Y
4.1
Median 5Y
4.2
Industry
23
vs History
79
vs Industry
73
Median 3Y
0.6
Median 5Y
0.6
Industry
2.3
vs History
76
vs Industry
75
Median 3Y
0.8
Median 5Y
0.9
Industry
2.9
vs History
57
vs Industry
62
Median 3Y
2.7
Median 5Y
2.8
Industry
5.6
vs History
9
vs Industry
21
Median 3Y
15.8
Median 5Y
11.3
Industry
13.2
vs History
vs Industry
0
Median 3Y
16
Median 5Y
18.1
Industry
16.6
vs History
19
vs Industry
33
Median 3Y
8
Median 5Y
13.3
Industry
15.8
vs History
9
vs Industry
11
Median 3Y
16.4
Median 5Y
17.1
Industry
19
vs History
76
vs Industry
70
Median 3Y
0.6
Median 5Y
0.7
Industry
2

Multiples Across Competitors

Competitors Multiples
Handok Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Handok Inc
KRX:002390
146.1B KRW 0.3 -2.8 25.5 -55.3
US
Eli Lilly and Co
NYSE:LLY
1T USD 17 54.8 36.8 39.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
497.5B USD 5.4 19.8 16.2 21
CH
Roche Holding AG
SIX:ROG
261.4B CHF 4.2 27.7 11.8 13.8
UK
AstraZeneca PLC
LSE:AZN
211.6B GBP 4.9 30.3 108.4 158.7
CH
Novartis AG
SIX:NOVN
210.3B CHF 4.7 18.4 11.7 15.1
US
Merck & Co Inc
NYSE:MRK
263.4B USD 4.1 13.8 9.8 11.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK 4.6 14 9.8 11.4
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143B USD 2.3 14.6 7.4 10.1
P/E Multiple
Earnings Growth PEG
KR
Handok Inc
KRX:002390
Average P/E: 24.2
Negative Multiple: -2.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.8
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.8
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.7
29%
1
UK
AstraZeneca PLC
LSE:AZN
30.3
37%
0.8
CH
Novartis AG
SIX:NOVN
18.4
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.8
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
14
3%
4.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
KR
Handok Inc
KRX:002390
Average EV/EBITDA: 402
25.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.8
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.8
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.4
10%
10.8
CH
Novartis AG
SIX:NOVN
11.7
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.8
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.8
1%
9.8
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
KR
Handok Inc
KRX:002390
Average EV/EBIT: 1 883.3
Negative Multiple: -55.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.4
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.8
6%
2.3
UK
AstraZeneca PLC
LSE:AZN
158.7
23%
6.9
CH
Novartis AG
SIX:NOVN
15.1
12%
1.3
US
Merck & Co Inc
NYSE:MRK
11.7
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
11.4
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.1
7%
1.4